Skip to content

An exploratory clinical study on the efficacy and safety of compound cryoprotectants in fat cryopreservation

An exploratory clinical study on the efficacy and safety of compound cryoprotectants in fat cryopreservation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036825
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial soft tissue depression

Interventions

Cryopreserved fat group:Transplant 5 ml cryopreserved fat
Control group:Transplant freshly aspirated fat 5 ml

Sponsors

Shanghai Jiao Tong University, School of Medicine, Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old; 2. Gender: male and female; 3. Patients with facial soft tissue depression needing fat transplantation; 4. Patients with symmetry bilateral facial depression; 5. They voluntarily signed informed consent, participated in the study and were able to cooperate with the follow-up workers.

Exclusion criteria

Exclusion criteria: (1) It is not suitable for fat transplantation; (2) Only unilateral soft tissue was depressed; (3) There were local lesions in the operation area, such as infection, blood supply disturbance, delayed healing history, decreased soft tissue vitality, history of radiotherapy or going to receive radiotherapy, active ulcer, etc; (4) Severe medical diseases (such as diabetes, hepatitis, coronary heart disease, arteriosclerosis, glomerulonephritis, autoimmune diseases, etc.) were complicated; (5) Those who are receiving anticoagulant therapy and cannot suspend treatment; (6) According to the laboratory examination and other clinical signs and symptoms, the researchers judged that the subjects had abnormal blood routine test, abnormal coagulation function, abnormal cardiac function, abnormal liver function or renal function (7) Those who can't tolerate the operation risk according to the surgeon's evaluation; (8) Pregnant and lactating women; (9) Those who have mental illness, have no insight, can not express and cooperate with each other; (10) In this study, participants in other clinical trials within 30 days before the visit were screened; (11) Those who have not signed the informed consent.

Design outcomes

Primary

MeasureTime frame
Retention volume;

Countries

China

Contacts

Public ContactShuang-Bai Zhou

Shanghai Jiao Tong University, School of Medicine, Shanghai Ninth People's Hospital

shuangbaizhou@yahoo.com+86 18521006693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026